PCFFS
WST icon

Pacific Center for Financial Services’s West Pharmaceutical WST Stock Holding History

Pacific Center for Financial Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.82K Hold
19
– – ﹤0.01% 369
2026
Q1 		$4.76K Hold
19
– – ﹤0.01% 386
2025
Q4 		$4.99K Hold
19
– – ﹤0.01% 372
2025
Q3 		$4.99K Hold
19
– – ﹤0.01% 372
2025
Q2 		$4.16K Hold
19
– – ﹤0.01% 370
2025
Q1 		$4.25K Hold
19
– – ﹤0.01% 365
2024
Q4 		$6.22K Hold
19
– – ﹤0.01% 347
2024
Q3 		$5.7K Hold
19
– – ﹤0.01% 351
2024
Q2 		$6.26K Hold
19
– – ﹤0.01% 337
2024
Q1 		$7.52K Buy
+19
New +$7.03K ﹤0.01% 329

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pacific Center for Financial Services's WST Position: Q2 2026 in Review

Pacific Center for Financial Services held its West Pharmaceutical (WST) position steady in Q2 2026 at 19 shares worth $6.82K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

Pacific Center for Financial Services first reported a position in WST in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.52K in Q1 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Pacific Center for Financial Services held 19 shares of West Pharmaceutical worth $6.82K as of Q2 2026.
  • Pacific Center for Financial Services left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Pacific Center for Financial Services's portfolio in Q2 2026, its #369 holding.
  • Pacific Center for Financial Services first reported a position in West Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • Pacific Center for Financial Services's West Pharmaceutical position peaked at $7.52K in Q1 2024.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.